Great Efficacy of Afatinib in a Patient with Lung Adenocarcinoma Harboring EGFR L833V/H835L Mutations: A Case Report

Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort

(2020) Yong Song et al.   Translational Lung Cancer Research

Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report

(2019) Ning An et al.   OncoTargets and Therapy

Worldwide Frequency of Commonly Detected EGFR Mutations

(2018) Rondell P. Graham et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Case Report: Osimertinib achieved remarkable and sustained disease control in an advanced non-small-cell lung cancer harboring EGFR H773L/V774M mutation complex

(2018) Minglei Yang et al.   LUNG CANCER

The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review

(2018) Bao-Dong Qin et al.   OncoTargets and Therapy

Potential for afatinib as an optimal treatment for advanced non-small cell lung carcinoma in patients with uncommon EGFR mutations

(2018) Ichidai Tanaka et al.   LUNG CANCER

Nonsmall cell lung cancer with rare exon 7 p.A289V mutation in the EGFR gene responds to Icotinib treatment

(2018) Limeng Dai et al.   MEDICINE

EGFR L858M/L861Q cis Mutations Confer Selective Sensitivity to Afatinib

(2017) Jamie A. Saxon et al.   Journal of Thoracic Oncology

A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer

(2017) Hai-Yan Tu et al.   LUNG CANCER

A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib

(2016) Stefano Frega et al.   Journal of Thoracic Oncology

Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study

(2016) Nicolas Pécuchet et al.   PLOS MEDICINE

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

(2015) James C-H Yang et al.   LANCET ONCOLOGY

A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer

(2014) SUQIN YI et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

A Sequential Method of Epidermal Growth Factor Receptor Mutation Detection Reduces False Negatives: A New Case With Doublet Mutations of L833V and H835L in China

(2013) Yuan Zhuang et al.   Clinical Lung Cancer

Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

(2012) Susumu Kobayashi et al.   Journal of Thoracic Oncology

Good Response to Gefitinib in a Lung Adenocarcinoma Harboring a Heterozygous Complex Mutation of L833V and H835L in Epidermal Growth Factor Receptor Gene

(2011) Tsung-Ying Yang et al.   JOURNAL OF CLINICAL ONCOLOGY